1890 related articles for article (PubMed ID: 9506190)
41. Type 2 diabetes care: the role of insulin-sensitizing agents and practical implications for cardiovascular disease prevention.
Henry RR
Am J Med; 1998 Jul; 105(1A):20S-26S. PubMed ID: 9707264
[TBL] [Abstract][Full Text] [Related]
42. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.
Nadeau DA
Postgrad Med; 2013 May; 125(3):112-26. PubMed ID: 23748512
[TBL] [Abstract][Full Text] [Related]
43. Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus.
Palumbo PJ
J Diabetes Complications; 1998; 12(2):110-9. PubMed ID: 9559489
[TBL] [Abstract][Full Text] [Related]
44. Addition of insulin to oral therapy in patients with type 2 diabetes.
Nelson SE; Palumbo PJ
Am J Med Sci; 2006 May; 331(5):257-63. PubMed ID: 16702795
[TBL] [Abstract][Full Text] [Related]
45. The management of the obese diabetic patient.
Albu J; Raja-Khan N
Prim Care; 2003 Jun; 30(2):465-91. PubMed ID: 14567159
[TBL] [Abstract][Full Text] [Related]
46. Pharmacotherapy for the treatment of patients with type 2 diabetes mellitus: rationale and specific agents.
Cefalu WT
Clin Pharmacol Ther; 2007 May; 81(5):636-49. PubMed ID: 17438539
[TBL] [Abstract][Full Text] [Related]
47. Insulin therapy in type II diabetes.
Koivisto VA
Diabetes Care; 1993 Dec; 16 Suppl 3():29-39. PubMed ID: 8299475
[TBL] [Abstract][Full Text] [Related]
48. Oral antidiabetic agents as cardiovascular drugs.
Macfarlane DP; Paterson KR; Fisher M
Diabetes Obes Metab; 2007 Jan; 9(1):23-30. PubMed ID: 17199715
[TBL] [Abstract][Full Text] [Related]
49. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
50. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
51. Swertisin rich fraction from Enicostema littorale ameliorates hyperglycemia and hyperlipidemia in high-fat fed diet and low dose streptozotacin induced type 2 diabetes mellitus in rats.
Mokashi P; Bhatt LK; Khanna A; Pandita N
Biomed Pharmacother; 2017 Dec; 96():1427-1437. PubMed ID: 29031588
[TBL] [Abstract][Full Text] [Related]
52. Practical considerations for the use of sodium-glucose co-transporter type 2 inhibitors in treating hyperglycemia in type 2 diabetes.
Lam KS; Chow CC; Tan KC; Ma RC; Kong AP; Tong PC; Tsang MW; Chan TM; Tang SC; Lee KK; So WY; Tomlinson B
Curr Med Res Opin; 2016 Jun; 32(6):1097-108. PubMed ID: 26933918
[TBL] [Abstract][Full Text] [Related]
53. [Insulin secretion and repaglinide].
Owens D
Diabetes Metab; 1999 Dec; 25 Suppl 7():17-9. PubMed ID: 10746006
[TBL] [Abstract][Full Text] [Related]
54. Pathophysiology of type 2 diabetes and its relationship to new therapeutic approaches.
Bell D
Diabetes Educ; 2000; 26 Suppl():4-7. PubMed ID: 11912815
[No Abstract] [Full Text] [Related]
55. Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus.
Henry RR
Ann Intern Med; 1996 Jan; 124(1 Pt 2):97-103. PubMed ID: 8554221
[TBL] [Abstract][Full Text] [Related]
56. New concepts in diabetes: how multihormonal regulation can improve glycemic control.
Blonde L; Baker DE; Davis SN; Ratner RE
J Manag Care Pharm; 2004 Dec; 10(6 Suppl B):S3-8; quiz S9, S11-2. PubMed ID: 23570175
[TBL] [Abstract][Full Text] [Related]
57. Insulin: either alone or combined with oral hypoglycemic agents.
Firth RG
Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969
[TBL] [Abstract][Full Text] [Related]
58. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
Jia DM; Tabaru A; Nakamura H; Fukumitsu KI; Akiyama T; Otsuki M
Metabolism; 2000 Sep; 49(9):1167-75. PubMed ID: 11016899
[TBL] [Abstract][Full Text] [Related]
59. Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.
Smiley D; Umpierrez G
Expert Opin Pharmacother; 2007 Jun; 8(9):1353-64. PubMed ID: 17563269
[TBL] [Abstract][Full Text] [Related]
60. Exercise training in obese diabetic patients. Special considerations.
Zierath JR; Wallberg-Henriksson H
Sports Med; 1992 Sep; 14(3):171-89. PubMed ID: 1439393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
